NYSE:GEN - Genesis Healthcare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.38 +0.05 (+3.76 %) (As of 03/19/2019 04:00 PM ET)Previous Close$1.33Today's Range$1.28 - $1.4052-Week Range$1.10 - $2.86Volume786,876 shsAverage Volume194,609 shsMarket Capitalization$223.12 millionP/E Ratio-0.65Dividend YieldN/ABeta1.04 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2017, it provided inpatient services through a network of 470 skilled nursing and assisted/senior living facilities, including 444 skilled nursing facilities and 26 stand-alone assisted/senior living facilities across 30 states. Genesis HealthCare, Inc. also supplied rehabilitation and respiratory therapy to approximately 1,600 healthcare locations in 46 states and the District of Columbia. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania. Receive GEN News and Ratings via Email Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Skilled nursing care facilities Sub-IndustryN/A SectorMedical Current SymbolNYSE:GEN Previous SymbolNYSE:SKH CUSIPN/A CIK1351051 Webwww.genesishcc.com Phone610-444-6350Debt Debt-to-Equity RatioN/A Current Ratio0.97 Quick Ratio0.97Price-To-Earnings Trailing P/E Ratio-0.65 Forward P/E Ratio-0.93 P/E GrowthN/A Sales & Book Value Annual Sales$5.37 billion Price / Sales0.04 Cash Flow$2.5556 per share Price / Cash Flow0.54 Book Value($10.54) per share Price / Book-0.13Profitability EPS (Most Recent Fiscal Year)($2.11) Net Income$-578,980,000.00 Net Margins-4.99% Return on EquityN/A Return on Assets-2.66%Miscellaneous Employees68,700 Outstanding Shares161,679,000Market Cap$223.12 million Next Earnings Date5/9/2019 (Estimated) OptionableOptionable Genesis Healthcare (NYSE:GEN) Frequently Asked Questions What is Genesis Healthcare's stock symbol? Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN." How were Genesis Healthcare's earnings last quarter? Genesis Healthcare Inc (NYSE:GEN) posted its quarterly earnings results on Monday, March, 18th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.24) by $0.43. The business had revenue of $1.19 billion for the quarter, compared to analysts' expectations of $1.21 billion. During the same quarter last year, the business posted ($0.92) EPS. View Genesis Healthcare's Earnings History. When is Genesis Healthcare's next earnings date? Genesis Healthcare is scheduled to release their next quarterly earnings announcement on Thursday, May 9th 2019. View Earnings Estimates for Genesis Healthcare. What price target have analysts set for GEN? 4 Wall Street analysts have issued 12-month price targets for Genesis Healthcare's shares. Their predictions range from $1.75 to $7.00. On average, they anticipate Genesis Healthcare's share price to reach $3.3125 in the next year. This suggests a possible upside of 140.0% from the stock's current price. View Analyst Price Targets for Genesis Healthcare. What is the consensus analysts' recommendation for Genesis Healthcare? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genesis Healthcare. Has Genesis Healthcare been receiving favorable news coverage? News headlines about GEN stock have trended somewhat negative this week, InfoTrie reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Genesis Healthcare earned a daily sentiment score of -1.9 on InfoTrie's scale. They also gave news stories about the company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the stock's share price in the immediate future. Who are some of Genesis Healthcare's key competitors? Some companies that are related to Genesis Healthcare include Natus Medical (BABY), Intrexon (XON), BioCryst Pharmaceuticals (BCRX), Dicerna Pharmaceuticals (DRNA), Veracyte (VCYT), Principia Biopharma (PRNB), Advanz Pharma (CXRXF), Radius Health (RDUS), NanoString Technologies (NSTG), Cerus (CERS), Global Cord Blood (CO), Addus Homecare (ADUS), Vericel (VCEL), AxoGen (AXGN) and Cellectis (CLLS). What other stocks do shareholders of Genesis Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Genesis Healthcare investors own include General Electric (GE), Rite Aid (RAD), Hecla Mining (HL), Eclipse Resources (ECR), Nuance Communications (NUAN), Advanced Micro Devices (AMD), Biocept (BIOC), Internap (INAP), Oragenics (OGEN) and Genocea Biosciences (GNCA). Who are Genesis Healthcare's key executives? Genesis Healthcare's management team includes the folowing people: Mr. George V. Hager Jr., CEO & Director (Age 63)Mr. Thomas DiVittorio, CFO, Sr. VP, Treasurer & Assistant Sec. (Age 51)Mr. Paul David Bach, COO & Exec. VP (Age 60)Dr. JoAnne Susan Reifsnyder Ph.D., MSN, MBA, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 60)Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 64) Who are Genesis Healthcare's major shareholders? Genesis Healthcare's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include First Washington CORP (2.07%), BlackRock Inc. (2.01%), Columbia Pacific Advisors LLC (2.00%), Acadian Asset Management LLC (1.05%), Prescott Group Capital Management L.L.C. (0.58%) and Northern Trust Corp (0.41%). Company insiders that own Genesis Healthcare stock include Daniel Allen Hirschfeld, David A Reis, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis Healthcare. Which major investors are selling Genesis Healthcare stock? GEN stock was sold by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., First Washington CORP, Virtu Financial LLC and Northern Trust Corp. Company insiders that have sold Genesis Healthcare company stock in the last year include David A Reis, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare. Which major investors are buying Genesis Healthcare stock? GEN stock was acquired by a variety of institutional investors in the last quarter, including Prescott Group Capital Management L.L.C., Millennium Management LLC, Acadian Asset Management LLC, RBF Capital LLC, Mackay Shields LLC, Columbia Pacific Advisors LLC, California Public Employees Retirement System and Geode Capital Management LLC. View Insider Buying and Selling for Genesis Healthcare. How do I buy shares of Genesis Healthcare? Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Genesis Healthcare's stock price today? One share of GEN stock can currently be purchased for approximately $1.38. How big of a company is Genesis Healthcare? Genesis Healthcare has a market capitalization of $223.12 million and generates $5.37 billion in revenue each year. The company earns $-578,980,000.00 in net income (profit) each year or ($2.11) on an earnings per share basis. Genesis Healthcare employs 68,700 workers across the globe. What is Genesis Healthcare's official website? The official website for Genesis Healthcare is http://www.genesishcc.com. How can I contact Genesis Healthcare? Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected] MarketBeat Community Rating for Genesis Healthcare (NYSE GEN)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 263 (Vote Outperform)Underperform Votes: 318 (Vote Underperform)Total Votes: 581MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe GEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/19/2019 by MarketBeat.com StaffFeatured Article: Why is Cost of Capital Important?